Featured Research

from universities, journals, and other organizations

A First In Robotic Heart Valve Surgery

Date:
May 3, 2000
Source:
New York University Medical Center And School Of Medicine
Summary:
NYU Medical Center cardiac surgeons and Computer Motion, Inc. have announced the first minimally invasive robotic heart valve surgery in the United States was successfully completed. On Friday, April 28th, Stephen Colvin, M.D., Chief of Cardiothoracic Surgery and Eugene A. Grossi, M.D., Director of Cardiac Surgical Research at NYU Medical Center, used the Computer Motion ZEUS Robotic Surgical System to perform the minimally invasive mitral valve repair on a 50-year-old male.

NYU Medical Center announces first minimally invasive robotic heart valve surgery in the United States

New York, NY, May 2, 2000 - NYU Medical Center cardiac surgeons, leaders in minimally invasive heart surgery techniques and Computer Motion, Inc., the leader in medical robotics, announced today the first minimally invasive robotic heart valve surgery in the United States was successfully completed. On Friday, April 28th, Stephen Colvin, M.D., Chief of Cardiothoracic Surgery and Eugene A. Grossi, M.D., Director of Cardiac Surgical Research at NYU Medical Center, used the Computer Motion ZEUS Robotic Surgical System to perform the minimally invasive mitral valve repair on a 50-year-old male as part of a United States Food and Drug Administration approved Phase I clinical study.

The robotics technology provides an operative field of view with 10 to 15 times magnification - a significant increase over the standard surgical loops, which only provide 3 to 4 times magnification. The robotics increases the safety of the procedure by allowing the surgeon to control the endoscope (a slender optical tube which is passed into the patient's body to see the operative site) and surgical instruments in real time from a workstation instead of standing throughout a long and complex procedure. The computer interface also has the ability to provide more exact needle placement, which is critical to the success of heart surgery.

Drs. Colvin and Grossi performed the minimally invasive procedure through a mini-thoracotomy (a 4-6 cm incision) in the patient's chest. As a result, the typical patient pain and trauma associated with a conventional approach to a valve repair was avoided. The morning after surgery, the patient reported little pain and was mobile and comfortable. The surgeons added, "The post-operative transesophageal echocardiogram (TEE) revealed that the mitral valve is no longer leaking, and the patient is scheduled to be discharged on Tuesday."

While seated at a workstation a few feet away from the patient, the surgeon controls three robotic arms on the operating table, which become his or her eyes and hands for the minimally invasive surgery. While viewing a video monitor to see the operative site, the surgeon manipulates conventional minimally invasive instrument handles at the workstation, as the robotics replicates these movements with the instrument tips at the operative site. The surgeon also has the ability to move the endoscope using simple voice commands to directly control the visualization during a procedure.

"NYU Medical Center is world-renowned in heart valve surgery, " said Robert W. Duggan, Chairman and CEO of Computer Motion. "We are very pleased to be working together with NYU to pioneer this new procedure and to lead the advancement of minimally invasive surgery."

Surgeons at NYU Medical Center will perform a total of 12 mitral valve surgeries as part of the Phase I trial.


Story Source:

The above story is based on materials provided by New York University Medical Center And School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

New York University Medical Center And School Of Medicine. "A First In Robotic Heart Valve Surgery." ScienceDaily. ScienceDaily, 3 May 2000. <www.sciencedaily.com/releases/2000/05/000502185715.htm>.
New York University Medical Center And School Of Medicine. (2000, May 3). A First In Robotic Heart Valve Surgery. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/05/000502185715.htm
New York University Medical Center And School Of Medicine. "A First In Robotic Heart Valve Surgery." ScienceDaily. www.sciencedaily.com/releases/2000/05/000502185715.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins